With the spring coming, it is time for change, also for REMAP-CAP. We have entered – again – the inter-pandemic stage, with over 90% of recruitment in non-COVID-19 infections since more than a year.

At the end of 2023, we look back at our recent achievements and take a sneak preview at 2024.

With Autumn knocking on the door, hospitalizations for pneumonia are expected to increase, and we are determined to continue contributing to finding better treatments for influenza and COVID-19.

REMAP-CAP is slowly transiting from the pandemic setting to the pre-pandemic scenario with a focus on severe CAP and improving our processes based upon the lessons learned during the pandemic.

With the pandemic calming down in Europe, REMAP-CAP still delivered important conclusions for patients.